Cancidas and acute graft versus host disease Patient Reports February 10, 2012
Cancidas Side Effects Report #5702909-5
Cancidas side effect was reported by a Physician from FRANCE on Apr 04, 2008. Male patient, 46 years of age, was diagnosed with pyrexia, evidence based treatment and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, cytomegalovirus infection
, systemic candida. Cancidas dosage: unknown. Patient died.Cancidas Side Effects Report #5705124-4
Cancidas side effect was reported by a Physician from FRANCE on Apr 04, 2008. Male patient, 46 years of age, was diagnosed with pyrexia, evidence based treatment and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute respiratory distress syndrome, cytomegalovirus infection
, systemic candida. Cancidas dosage: unknown. Patient died.Cancidas Side Effects Report #5693675-0
Cancidas side effect was reported by a Physician from BELGIUM on Mar 28, 2008. Male patient, child 5 years of age, weighting 41.89 lb, was diagnosed with evidence based treatment, transplant and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, no adverse event, transaminases increased. Cancidas dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient was hospitalized. Patient died on 03/26/2008.
Cancidas Side Effects Report #5696008-9
Cancidas side effect was reported by a Physician from BELGIUM on Mar 28, 2008. Male patient, child 5 years of age, weighting 41.89 lb, was diagnosed with evidence based treatment, transplant and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, no adverse event, transaminases increased. Cancidas dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient was hospitalized. Patient died on 03/26/2008.
Cancidas Side Effects Report #5332741-6
Cancidas side effect was reported by a Physician from ITALY on May 15, 2007. Female patient, child 7 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia, bronchopulmonary aspergillosis, chronic graft versus host disease, hyperglycaemia, metabolic encephalopathy. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, FLUDARABINE PHOSPHATE, ETOPOSIDE, MELPHALAN, ANTILYMPHOCYTE IMMUNOGLOBULIN, METHOTREXATE, CYCLOSPORINE. Patient died.
Cancidas Side Effects Report #5337586-9
Cancidas side effect was reported by a Physician from ITALY on May 15, 2007. Female patient, child 7 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia, bronchopulmonary aspergillosis, chronic graft versus host disease, hyperglycaemia, metabolic encephalopathy. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, FLUDARABINE PHOSPHATE, ETOPOSIDE, MELPHALAN, ANTILYMPHOCYTE IMMUNOGLOBULIN, METHOTREXATE, CYCLOSPORINE. Patient died.
Cancidas Side Effects Report #5412948-X
Cancidas side effect was reported by a Physician from ITALY on Aug 03, 2007. Female patient, child 7 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia, bronchopulmonary aspergillosis, chronic graft versus host disease, hyperglycaemia, metabolic encephalopathy. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B. Patient died.
Cancidas Side Effects Report #5329280-5
Cancidas side effect was reported by a Physician from FRANCE on May 08, 2007. Male patient, 46 years of age, was diagnosed with antifungal prophylaxis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, cytomegalovirus infection
, respiratory failure, systemic candida. Cancidas dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient died.Cancidas Side Effects Report #5332298-X
Cancidas side effect was reported by a Physician from FRANCE on May 08, 2007. Male patient, 46 years of age, was diagnosed with antifungal prophylaxis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, cytomegalovirus infection
, respiratory failure, systemic candida. Cancidas dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient died.Cancidas Side Effects Report #5400473-1
Cancidas side effect was reported by a Physician from FRANCE on July 20, 2007. Male patient, 46 years of age, was diagnosed with antifungal prophylaxis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, cytomegalovirus infection
, respiratory failure, systemic candida. Cancidas dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient died.Cancidas Side Effects Report #5702912-5
Cancidas side effect was reported by a Physician from FRANCE on Apr 04, 2008. Male patient, 32 years of age, was diagnosed with antifungal prophylaxis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, bacteraemia, cytomegalovirus infection
, systemic candida. Cancidas dosage: unknown. Patient died.Cancidas Side Effects Report #5705129-3
Cancidas side effect was reported by a Physician from FRANCE on Apr 04, 2008. Male patient, 32 years of age, was diagnosed with antifungal prophylaxis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute respiratory distress syndrome, bacteraemia, candidiasis, cytomegalovirus infection
, systemic candida. Cancidas dosage: unknown. Patient died.
Cancidas and acute graft versus host disease 